Henderson R, Verougstraete V, Anderson K, Arbildua JJ, Brock TO, Brouwers T, Cappellini D, Delbeke K, Herting G, Hixon G, Odnevall Wallinder I, Rodriguez PH, Van Assche F, Wilrich P, Oller AR. 2013. Interlaboratory comparison of bioaccessibility tests for metals. Annual meeting of the Belgian Society for Toxicology and Ecotoxicology (BelTox).
Publication: Abstracts and Presentations
MacDonell MM, Haroun LA, Teuschler LK, Rice ER, Hertzberg RC, Butler JP, Chang Y, Clark S, Johns AP, Perry CS , Garcia SS, Jacobi JH, Scofield MA. 2013. Cumulative risk assessment toolbox: Methods and approaches for the practitioner. J Toxicol 2013:310904.
View Abstract
Publication: Manuscripts
Mounho-Zamora B. 2013. Regulatory standards for the approval of biosimilar products: A global review. In Weinbauer GF, Vogel F, eds. Challenges in Nonhuman Primate Research in the 21st Century. Waxmann, pg 9-34.
Publication: Book Chapters
Dourson ML, Gadagbui B, Griffin S, Garabrant DH, Haws LC , Kirman C, Tohyama C. 2013. The importance of problem formulations in risk assessment: A case study involving dioxin-contaminated soil. Regul Toxicol Pharmacol 66(2):208-216.
View Abstract
Publication: Manuscripts
Kirman CR, Aylward LL, Suh M , Harris MA , Thompson CM , Haws LC , Proctor DM , Lin SS, Parker W, Hays SM. 2013. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chem Biol Interact 204(1):13-27. doi:pii: S0009-2797(13)00082-3. 10.1016/j.cbi.2013.04.003.
View Abstract
Publication: Manuscripts
/ Topics: Cr(VI) MOA Study Manuscripts
Lamm SH, Britt JK, James RC. 2013. Multiple myeloma risk and benzene exposure among pliofilm workers – A re-analysis using an internal reference group. Presented at the Society of Toxicology’s 52nd Annual Meeting, March 10-14, San Antonio, TX.
View Abstract
Publication: Abstracts and Presentations
O’Brien T, Ding H, Suh M , Thompson C , Parsons BL, Harris MA, Winkelman WA, Wolf JC, Hixon JG, Schwartz AM, Myers MB, Haws LC , Proctor DM. 2013. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water. Mutat Res 754:15-21. doi: 10.1016/j.mrgentox.2013.03.008
View Abstract
Publication: Manuscripts
/ Topics: Cr(VI) MOA Study Manuscripts , Hexavalent Chromium
Wikoff D, Fitzgerald L, Haws L, Harris M. 2013. Health-based framework for evaluating the safety of hydraulic fracturing products. Presented at the Society of Toxicology’s 52nd Annual Meeting, March 10-14, San Antonio, TX.
View Abstract
Publication: Abstracts and Presentations
Rowlands JC, Budinsky R, Gollapudi B, Black MB, Wolfinger RD, Cukovic D, Bombkowski A, Thompson CM , Urban JD , Thomas RS. 2013. A genomics-based analysis of relative potencies of dioxin-like compounds in primary rat hepatocytes. Toxicol Sci 136(2):595-604.
View Abstract
Publication: Manuscripts
Thompson CM , Proctor DM , Suh M , Haws LC , Kirman CR, Harris MA . 2013. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol 43(3): 244-274.
View Abstract